The clinical trials conducted by Mark R. Litzow, M.D., at Mayo Clinic and through the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) relate to the integral role the Division of Hematology at Mayo Clinic plays in ECOG-ACRIN through active participation in the Myeloma, Lymphoma and Leukemia committees.
- Blood and marrow transplant for acute and chronic leukemia and solid tumors
- Immunologic therapy of hematologic malignancies
- Chemotherapy and drug treatment of acute leukemia and chronic myeloid leukemia
Significance to patient care
Dr. Litzow is a professor of medicine and the head of the Acute Leukemia Group at Mayo Clinic's campus in Rochester, Minnesota. He served as the director of the Blood and Marrow Transplant (BMT) Program at Mayo Clinic for 17 years, and remains an active member of the BMT Program.
Dr. Litzow chairs the Leukemia Committee of ECOG-ACRIN and has been involved in the development of large phase II and phase III clinical trials for over 20 years. He has also been a longstanding and active member of the Acute Leukemia Committee for the Center for International Blood and Marrow Transplant Research.
These efforts have contributed to improvements in outcomes for patients with acute leukemia and chronic myeloid disorders and to improved survival of patients after blood and marrow transplantation.
- Chair, Leukemia Committee, Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN), 2013-present
- Chair, Myeloid Disease Oriented Group, Mayo Clinic, 2002-present
- Distinguished Mayo Clinician, Mayo Clinic, 2010